SCHEMBL5114907

SCHEMBL5114907

COc1ccc(CC(C)(C)O)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.59
CYP19A1 P11511 1/20 0.53
ATM Q13315 2/20 0.52
KDM4E B2RXH2 2/20 0.52
ALDH1A1 P00352 2/20 0.50
PPARG P37231 1/20 0.50
PPARD Q03181 1/20 0.50
PPARA Q07869 1/20 0.50
LDHA P00338 1/20 0.50
POLB P06746 3/20 0.49
STAT3 P40763 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 1/20 0.47
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
MTNR1A P48039 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29944152 0.87 CA2 (0.57) CA2CYP19A1ATMKDM4EALDH1A1
SCHEMBL28409555 0.85 CA2 (0.55) CA2CYP19A1ATMKDM4EALDH1A1
SCHEMBL3057081 0.85 CYP1A2 (0.57) CYP19A1CYP1A2CYP3A4
SCHEMBL74008 0.84 CA2 (0.63) CA2CYP19A1ATMKDM4EALDH1A1
SCHEMBL27545972 0.84 KMT2A (0.50) ALDH1A1CYP1A2CYP3A4CYP2D6SMN1; SMN2
SCHEMBL16114691 0.84 MAPT (0.49) KDM4EALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL15569845 0.84 CA2 (0.53) CA2CYP19A1ATMKDM4EALDH1A1
SCHEMBL5114730 0.82 CA2 (0.61) CA2CYP19A1ATMKDM4EALDH1A1
SCHEMBL6791052 0.81 ATM (0.58) CA2CYP19A1ATMKDM4EPOLB
SCHEMBL11552660 0.81 CA2 (0.55) CA2CYP19A1ATMKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096942-A1 Substituted Hydroxyethylamines ELAN PHARMACEUTICALS, INC. 2008-04-24 US disclosed
US-7312360-B2 Substituted hydroxyethylamines ELAN PHARMACEUTICALS, INC. (US) 2007-12-25 US disclosed
US-20040044072-A1 Substituted hydroxyethylamines PHARMACIA & UPJOHN COMPANY 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096942-A1 Substituted Hydroxyethylamines BACE1, BACE2, MME CA2 3235/4885CYP19A1 673/4885ATM 3280/4885
US-20040044072-A1 Substituted hydroxyethylamines BACE1, BACE2, PSEN1 CA2 3191/4885CYP19A1 421/4885ATM 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.